Log in

ETR:MOR - MorphoSys Stock Price, Forecast & News

€117.80
-1.20 (-1.01 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
€117.60
Now: €117.80
€121.60
50-Day Range
€110.00
MA: €124.47
€136.20
52-Week Range
€79.70
Now: €117.80
€131.00
Volume160,900 shs
Average Volume153,687 shs
Market Capitalization$3.73 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States. The company, together with its pharmaceutical partners, develops a therapeutic pipeline of approximately 115 drugs for various diseases, such as psoriasis, Alzheimer's diseases, haematological malignancies, solid tumors, hemophilia, multiple myeloma, metabolic diseases, inflamation, thrombosis, brittle bone syndrome, eye diseases, cancers, diabetic eye diseases, blood disorders, and asthma. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-89-899270

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$71.16 million
Cash Flow€11.16 per share
Book Value€13.99 per share

Profitability

Miscellaneous

Employees329
Market Cap$3.73 billion
Next Earnings Date3/18/2020 (Estimated)
OptionableNot Optionable

Receive MOR News and Ratings via Email

Sign-up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter.


MorphoSys (ETR:MOR) Frequently Asked Questions

What is MorphoSys' stock symbol?

MorphoSys trades on the ETR under the ticker symbol "MOR."

When is MorphoSys' next earnings date?

MorphoSys is scheduled to release their next quarterly earnings announcement on Wednesday, March 18th 2020. View Earnings Estimates for MorphoSys.

What price target have analysts set for MOR?

7 brokerages have issued 1-year price objectives for MorphoSys' shares. Their forecasts range from €81.00 to €150.00. On average, they expect MorphoSys' stock price to reach €122.71 in the next year. This suggests a possible upside of 4.2% from the stock's current price. View Analyst Price Targets for MorphoSys.

What is the consensus analysts' recommendation for MorphoSys?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MorphoSys in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MorphoSys.

Has MorphoSys been receiving favorable news coverage?

Media stories about MOR stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. MorphoSys earned a news impact score of 1.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for MorphoSys.

Who are some of MorphoSys' key competitors?

What other stocks do shareholders of MorphoSys own?

Who are MorphoSys' key executives?

MorphoSys' management team includes the folowing people:
  • Dr. Simon E. Moroney, Chairman of Management Board & CEO (Age 59)
  • Mr. Jens H. Holstein, CFO & Member of Management Board (Age 55)
  • Dr. Markus Enzelberger, Chief Scientific Officer & Member of Management Board (Age 49)
  • Dr. Malte Peters, Chief Devel. Officer & Member of Management Board (Age 57)
  • Mr. Klaus De Wall, Head of Accounting & Tax

What is MorphoSys' stock price today?

One share of MOR stock can currently be purchased for approximately €117.80.

How big of a company is MorphoSys?

MorphoSys has a market capitalization of $3.73 billion and generates $71.16 million in revenue each year. MorphoSys employs 329 workers across the globe.View Additional Information About MorphoSys.

What is MorphoSys' official website?

The official website for MorphoSys is http://www.morphosys.de/.

How can I contact MorphoSys?

MorphoSys' mailing address is Semmelweisstr. 7, PLANEGG, 82152, Germany. The company can be reached via phone at +49-89-899270.


MarketBeat Community Rating for MorphoSys (ETR MOR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  220 (Vote Underperform)
Total Votes:  503
MarketBeat's community ratings are surveys of what our community members think about MorphoSys and other stocks. Vote "Outperform" if you believe MOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel